Accelix has developed a revolutionary cartridge-based multi-wavelength fluorescent event detection and analysis platform for rapid and efficient measurement and characterization of fluorescently labeled cells and beads to enable multiplexed immunoassays. LeukoDx’s Accellix platform is a no prep, push-button cell enumeration and characterization platform that can provide multiple fluorescent marker information in a single cartridge with close to real time access, 24/7 when and where critical decisions must be made. LeukoDx has offices in San Jose, CA and Jerusalem, Israel